The yellow polyphenol of turmeric · anti-inflammatory comparable to ibuprofen in osteoarthritis (Daily 2016 meta) without GI toxicity. But free curcumin has only 1% oral bioavailability · only patented forms (Meriva, Theracurmin, BCM-95) are therapeutically useful.
7Curcumin appears in 7 protocols personalizable→Yellow polyphenol from Curcuma longa · potent NF-κB and COX-2 inhibitor · but oral bioavailability of free form is 1% · need patented bioavailable forms.
Curcumin (diferuloylmethane) is the main bioactive polyphenol of turmeric (Curcuma longa) · 2-5% of the root's dry weight. It's one of the most studied natural anti-inflammatories (over 19,000 PubMed publications) · potently inhibits NF-κB, COX-2, TNF-α, IL-6 · activates Nrf2 (endogenous antioxidant pathway).
Critical problem: free curcumin has only 1% oral bioavailability. Reasons: nearly null water solubility, rapid intestinal metabolism (glucuronidation + sulfation), accelerated biliary excretion. Taking turmeric powder or curcumin capsules without bioavailability technology is practically throwing money away.
Three patented technologies solve the problem with clinical evidence: Meriva® (Indena · phytosome with phosphatidylcholine · 29× bioavailability), Theracurmin® (colloidal curcumin · 27× bioavailability), BCM-95® (curcumin + turmeric essential oils · 7-8× bioavailability). Basic form with piperine (BioPerine) increases 20× but with drug interaction risk.
5 pivotal studies · osteoarthritis meta-analysis · Alzheimer trial · inflammaging biomarkers · comparative bioavailability.
| Study | Finding | Hallmarks |
|---|---|---|
Curcumin in osteoarthritis · meta-analysis Daily et al · J Med Food 2016 | Meta 8 RCTs · n=606 patients with knee osteoarthritis · 1000-1500 mg/day curcumin (various forms) for 8-12 weeks · pain (WOMAC) reduction equivalent to ibuprofen 1200 mg/d without GI toxicity · function significantly improved. | OsteoarthritisInflamm. |
Theracurmin in mild cognitive impairment · neuroimaging trial Small et al · Am J Geriatr Psychiatry 2018 | 18-month RCT · n=40 adults 51-84 years non-demented · 90 mg Theracurmin 2× day · significant visual and verbal memory improvement vs placebo + reduction amyloid and tau accumulation in amygdala/hypothalamus by PET. | CognitionAmyloid |
Curcumin and major depression · meta-analysis Ng et al · J Clin Psychiatry 2017 | Meta 6 RCTs · n=377 major depression patients · 500-1,000 mg/day curcumin (various forms) · Hamilton Depression reduction similar to antidepressants in subgroups · mechanism via inflammaging + monoamines. | DepressionInflamm. |
Meriva phytosome · bioavailability 29× Cuomo et al · J Nat Prod 2011 | Comparative PK study humans n=9 · 376 mg Meriva (75 mg curcumin) vs 1,800 mg conventional curcumin · plasma AUC 29× higher with Meriva. Confirms massive pharmacokinetic superiority of phytosomal technology. | Bioavail.PK |
Curcumin and inflammaging markers · meta Mantzorou et al · Foods 2018 | Meta 25 RCTs · n=1,495 · bioavailable curcumin reduces CRP −3.7 mg/L, IL-6 −0.36 pg/mL, TNF-α −4.7 pg/mL. Magnitudes comparable to statins on CRP. Robust evidence chronic anti-inflammaging effect. | CRPInflamm. |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
Meriva 1000 mg/day (= 200 mg pure curcumin) · Theracurmin 90-180 mg 2× day · BCM-95 500 mg 2× day. Always with fatty meal.
Start modest dose to evaluate GI tolerance. Take with fatty breakfast (olive oil, avocado, yogurt). Some patients notice mild initial nausea · attenuates.
Daily 2016 meta dose for osteoarthritis and CRP reduction. Equals ~5 g raw turmeric · impossible from diet. Divide in 2 doses (morning + evening) for plasma stability.
Small 2018 RCT cognition dose · detectable difference in memory + amyloid biomarkers at 18 months. Theracurmin is the only form with human neuroimaging evidence.
Complementary polyphenols · curcumin (NF-κB) + resveratrol (SIRT1) + quercetin (CD38 + senolytic). Complete anti-inflammaging stack · cardinal mechanistic synergy.
Chemical/technological form ABSOLUTELY critical · free curcumin is useless. The 3 patented forms have human RCT data.
Absolute criterion: patented technology with human RCT · Meriva® / Theracurmin® / BCM-95®. Avoid generic curcumin without bioavailability technology.
Dose: 500 mg Meriva® × 2/day (= 200 mg curcumin)
Form: Meriva® phytosome · Indena license
Cert.: NSF · GMP · third-party tested
Fillers: Vegetable capsule · zero problematic excipients
Dose: 500 mg Meriva® × 2/day
Form: Meriva® Indena licensed
Cert.: GMP · vegan · non-GMO
Fillers: Cellulose · Mg stearate
Dose: 40 mg curcumin equivalent to 1,000 mg standard/day
Form: LongVida® curcumin (lipid system)
Cert.: GMP · kosher · vegan
Fillers: Sunflower oil · natural vitamin E
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
3 biomarkers · high-sensitivity CRP (main) + IL-6 + omega-6:3 ratio (total inflammaging).
High-sensitivity CRP (hs-CRP). Cardinal inflammaging marker · target <1 mg/L · Mantzorou 2018 meta showed reduction −3.7 mg/L with bioavail curcumin. ~10 € general analytic. Measure baseline and 12 weeks post-supplementation.
IL-6. Key pro-inflammatory cytokine · target <3 pg/mL. Curcumin reduces 0.4 pg/mL typical. ~25 € specialized analytic. Better CV mortality predictor than CRP in some contexts.
Plasma omega-6 : omega-3 ratio. Total inflammaging · target <4:1. Curcumin alone doesn't affect · combo with omega-3 does. Useful to evaluate complete stack. ~35 € fatty acid profile analytic.
hs-CRP + IL-6 + TNF-α + omega-6:3 ratio + ferritin + homocysteine. Panel evaluates chronic inflammaging · ideal to measure pre/post curcumin + omega-3.
Good safety profile · but real interactions via anti-platelet + CYP450 inhibition (especially forms with piperine).
4 combos · curcumin is NF-κB anti-inflammatory · each combo covers complementary inflammaging pathway.
Curcumin inhibits COX-2 · omega-3 reduces substrate (arachidonic acid) and provides resolvins. Combo modulates inflammation via two complementary pathways · robust clinical synergy.
Both polyphenols modulate NF-κB but via distinct mechanisms · curcumin direct inhibition, resveratrol via SIRT1 → NF-κB. Cardinal anti-inflammaging stack.
Mild senolytics · curcumin + quercetin combined eliminate more senescent cells than each alone. Niedernhofer 2023 emerging combo.
If basic form (not Meriva/Theracurmin) · piperine increases bioavail 20× · but caution polypharmacy (inhibits CYP3A4). Only if NOT taking multiple drugs.
8 real questions · literature-based answers · critical emphasis on bioavailability.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.